Your browser doesn't support javascript.
loading
Different Approach to Manage Demodex Blepharitis - Initial and Maintenance Treatment.
Jacobi, Christina; Doan, Serge; Pavel, Viktoria; Chiambaretta, Frédéric; Kärcher, Thomas.
Afiliação
  • Jacobi C; Ophthalmology Private Practice, Nuremberg, Germany.
  • Doan S; Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen-Nuremberg, Germany.
  • Pavel V; Fondation a de Rothschild, Paris, France.
  • Chiambaretta F; proDERM Institute for Applied Dermatological Research, Hamburg, Germany.
  • Kärcher T; University Hospital of Clermont-Ferrand, Chu Clermont-Ferrand, Ophthalmology, Clermont-Ferrand, France.
Curr Eye Res ; 47(3): 352-360, 2022 03.
Article em En | MEDLINE | ID: mdl-34565266
ABSTRACT
PURPOSE/AIM OF THE STUDY To evaluate the improvement of ocular signs and symptoms in patients suffering from Demodex blepharitis using a combined treatment

approach:

use of eyelid wipes impregnated with 2.5% terpinen-4-ol (T4O) and 0.2% hyaluronic acid (HA) in the initial treatment period and investigation of maintenance of the treatment effect with the use of eyelid cleansing wipes. MATERIALS AND

METHODS:

Fifty patients with Demodex blepharitis were treated in the initial treatment period with sterile eyelid T4O impregnated wipes for 28 days. In the following four-week maintenance period, 82% patients received sterile eyelid maintenance wipes, while 16% continued treatment with T4O impregnated wipes. Global ocular discomfort, adapted TOSS, SANDE score, and individual blepharitis symptoms were assessed by patients at day 28 and day 56. Ocular signs were evaluated by the investigator at the study visits. Investigator's assessment of the overall treatment performance, patient's assessment of treatment satisfaction, and tolerability were evaluated with questionnaires.

RESULTS:

All global ocular discomfort symptoms and disease specific symptoms assessed by patients as well as all parameters evaluated by the investigators significantly improved in the initial treatment period with the application of eyelid wipes impregnated with 2.5% terpinen-4-ol until day 28. The therapeutic effect was maintained or even improved during the maintenance period under administration of mainly eyelid maintenance wipes until day 56. Both products were well tolerated. No adverse events and no clinically relevant changes in visual acuity were observed during both periods.

CONCLUSIONS:

Once daily treatment with T4O impregnated eyelid wipes in the initial treatment period significantly improved the ocular symptoms and signs and reduced the mite count in patients with Demodex blepharitis within four-weeks administration. Subsequent maintenance treatment with maintenance wipes for another 4 weeks preserved or further intensified the treatment success. The products were well tolerated and were convenient to use.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Blefarite / Infecções Oculares Parasitárias / Pestanas / Infestações por Ácaros / Ácaros Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Blefarite / Infecções Oculares Parasitárias / Pestanas / Infestações por Ácaros / Ácaros Idioma: En Ano de publicação: 2022 Tipo de documento: Article